These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12100534)

  • 1. Pancreatic toxicity after liposomal amphotericin B.
    Stuecklin-Utsch A; Hasan C; Bode U; Fleischhack G
    Mycoses; 2002 Jun; 45(5-6):170-3. PubMed ID: 12100534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Walsh TJ; Finberg RW; Arndt C; Hiemenz J; Schwartz C; Bodensteiner D; Pappas P; Seibel N; Greenberg RN; Dummer S; Schuster M; Holcenberg JS
    N Engl J Med; 1999 Mar; 340(10):764-71. PubMed ID: 10072411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients.
    Chopra R; Blair S; Strang J; Cervi P; Patterson KG; Goldstone AH
    J Antimicrob Chemother; 1991 Oct; 28 Suppl B():93-104. PubMed ID: 1778896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.
    Krüger W; Stockschläder M; Sobottka I; Betker R; De Wit M; Kröger N; Grimm J; Arland M; Fiedler W; Erttmann R; Zander AR
    Leuk Lymphoma; 1997 Feb; 24(5-6):491-9. PubMed ID: 9086439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of fungal infections in neutropenic patients with liposomal amphotericin (AmBisome)--a report on 40 cases from a single centre.
    Chopra R; Fielding A; Goldstone AH
    Leuk Lymphoma; 1992; 7 Suppl():73-7. PubMed ID: 1493462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation.
    Krüger W; Stockschläder M; Rüssmann B; Berger C; Hoffknecht M; Sobottka I; Kohlschütter B; Kroschke G; Kröger N; Horstmann M
    Br J Haematol; 1995 Nov; 91(3):684-90. PubMed ID: 8555076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].
    Rieger CT; Dittmer M; Ostermann H
    Dtsch Med Wochenschr; 2007 Oct; 132(40):2062-6. PubMed ID: 17899499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of comparative studies between conventional and liposomal amphotericin B (Ambisome) in neutropenic patients with fever of unknown origin and patients with systemic mycosis.
    Blau IW; Fauser AA
    Mycoses; 2000 Oct; 43(9-10):325-32. PubMed ID: 11105535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
    Walsh TJ; Teppler H; Donowitz GR; Maertens JA; Baden LR; Dmoszynska A; Cornely OA; Bourque MR; Lupinacci RJ; Sable CA; dePauw BE
    N Engl J Med; 2004 Sep; 351(14):1391-402. PubMed ID: 15459300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of amphotericin B colloidal dispersion in children.
    Sandler ES; Mustafa MM; Tkaczewski I; Graham ML; Morrison VA; Green M; Trigg M; Abboud M; Aquino VM; Gurwith M; Pietrelli L
    J Pediatr Hematol Oncol; 2000; 22(3):242-6. PubMed ID: 10864055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal amphotericin B in critically ill paediatric patients.
    Sideri G; Falagas ME; Grigoriou M; Vouloumanou EK; Papadatos JH; Lebessi E; Kafetzis DA
    J Clin Pharm Ther; 2012 Jun; 37(3):291-5. PubMed ID: 21777406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemopoietic cell transplantation of patients with a history of deep or invasive fungal infection during prophylaxis with liposomal amphotericin B.
    Krüger WH; Rüssmann B; de Wit M; Kröger N; Renges H; Sobottka I; Zander AR
    Acta Haematol; 2005; 113(2):104-8. PubMed ID: 15802888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of deep mycoses with liposomal amphotericin B.
    Berenguer J; Muñoz P; Parras F; Fernández-Baca V; Hernández-Sampelayo T; Bouza E
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):504-7. PubMed ID: 7957273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of systemic fungal infections with liposomal amphotericin B.
    Lopez-Berestein G; Bodey GP; Fainstein V; Keating M; Frankel LS; Zeluff B; Gentry L; Mehta K
    Arch Intern Med; 1989 Nov; 149(11):2533-6. PubMed ID: 2818111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance of high doses of amphotericin B by infusion of a liposomal formulation in children with cancer.
    Emminger W; Graninger W; Emminger-Schmidmeier W; Zoubek A; Pillwein K; Susani M; Wasserer A; Gadner H
    Ann Hematol; 1994 Jan; 68(1):27-31. PubMed ID: 8110875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal amphotericin B (AmBisome) for fungal infections in immunocompromised adults and children.
    Tollemar J; Klingspor L; Ringdén O
    Clin Microbiol Infect; 2001; 7 Suppl 2():68-79. PubMed ID: 11525221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal amphotericin B for the treatment of severe fungal infection.
    Michaud D
    Dynamics; 2001; 12(1):17-21. PubMed ID: 11982230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with multilamellar liposomal amphotericin B in patients with proven and suspected fungal infections.
    Ralph ED; Barber KR; Grant CW
    Scand J Infect Dis; 1993; 25(4):487-96. PubMed ID: 8248749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.
    Prentice HG; Hann IM; Herbrecht R; Aoun M; Kvaloy S; Catovsky D; Pinkerton CR; Schey SA; Jacobs F; Oakhill A; Stevens RF; Darbyshire PJ; Gibson BE
    Br J Haematol; 1997 Sep; 98(3):711-8. PubMed ID: 9332329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India.
    Jadhav MP; Shinde VM; Chandrakala S; Jijina F; Menon H; Arora B; Kurkure PA; Parikh PM; Kshirsagar NA
    Indian J Cancer; 2012; 49(1):107-13. PubMed ID: 22842177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.